ABSTRACT
Purpose
To design and synthesize chemoembolization particles for the delivery of Ophiobolin A (OphA), a promising fungal-derived chemotherapeutic, directly at the tumour location. To investigate cell death mechanism of OphA on a Rhabdomyosarcoma cancer (RD) cell line. Rhabdomyosarcoma is the most common soft tissue sarcoma in children; with a 5-year survival rate of between 30 and 65%.
Methods
Multimodal chemoembolization particles were prepared by sintering mesoporous silica nanoparticles, prepared by the sol-gel method, onto the surface of polystyrene microspheres, prepared by suspension copolymerisation. The chemoembolization particles were subsequently loaded with OphA. The effects of OphA in vitro were characterised by flow cytometry and nanoparticle tracking analysis (NanoSight).
Results
High loading of OphA onto the chemoembolization particles was achieved. The subsequent release of OphA onto RD cells in culture showed a 70% reduction in cell viability. OphA caused RD cells to round up and their membrane to bleb and caused cell death via apoptosis. OphA caused both an increase in the number of microvesicles produced and an increase in DNA content within these microvesicles.
Conclusions
The prepared chemoembolization particles showed good efficacy against RD cells in culture.
Similar content being viewed by others
Abbreviations
- AIBN:
-
Azobisisobutyronitrile
- CTAB:
-
Cetyl trimethylammonium bromide
- CytoD:
-
CytochalasinD
- DCM:
-
Dichloromethane
- DMEM:
-
Dulbecco’s Modified Eagle’s Medium
- EGDMA:
-
Ethylene glycol dimethacrylate
- Em:
-
Emission
- Ex:
-
Excitation
- GFP:
-
Green fluorescent protein
- HMSNP:
-
Hexagonal mesoporous silica nanoparticles
- LC:
-
Liquid chromatography
- mtDNA:
-
Mitochondrial DNA
- NTA:
-
Nanoparticle tracking analysis
- OphA:
-
Ophiobolin A
- PBS:
-
Phosphate buffered saline
- PI:
-
Propidium iodide
- PS:
-
Polystyrene spheres
- PS-HMSNP:
-
Polystyrene-(hexagonal mesoporous silica nanoparticle) composite particles
- PVA:
-
Poly(vinyl alcohol)
- RD:
-
Rhabdomyosarcoma cancer cell line
- RMS:
-
Rhabdomyosarcoma
- SD:
-
Standard deviation
- SEM:
-
Scanning electron microscopy
- TEM:
-
Transmission electron microscopy
- TEOS:
-
Tetraethyl orthosilicate
REFERENCES
Shin SW. The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma. Korean J Radiol. 2009;10(5):425–34.
Liu X, Wan Sia Heng P, Li Q, Chan LW. Novel polymeric microspheres containing norcantharidin for chemoembolization. J Control Release. 2006;116(1):35–41.
Argyo C, Weiss V, Bräuchle C, Bein T. Multifunctional mesoporous silica nanoparticles as a universal platform for drug delivery. Chem Mater. 2014;26:435–51.
Slowing II, Vivero-Escoto JL, Wu C-W, Lin VSY. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev. 2008;60(11):1278–88.
Au TK, Chick WSH, Leung PC. The biology of ophiobolins. Life Sci. 2000;67(7):733–42.
Chattopadhyay AK, Samaddar KR. Effects of Helminthosporium oryzae infection and ophiobolin on the cell membranes of host tissues. Physiol Plant Pathol. 1976;8(2):131–9.
Leung PC, Taylor WA, Wang JH, Tipton CL. Ophiobolin-A—a natural product inhibitor of calmodulin. J Biol Chem. 1984;259(5):2742–7.
Bury M, Novo-Uzal E, Andolfi A, Cimini S, Wauthoz N, Heffeter P, et al. Ophiobolin A, a sesterterpenoid fungal phytotoxin, displays higher in vitro growth-inhibitory effects in mammalian than in plant cells and displays in vivo antitumor activity. Int J Oncol. 2013;43(2):575–85.
de Vries-van Leeuwen IJ, Kortekaas-Thijssen C, Nzigou Mandouckou JA, Kas S, Evidente A, de Boer AH. Fusicoccin-A selectively induces apoptosis in tumor cells after interferon-α priming. Cancer Lett. 2010;293(2):198–206.
Giacalone PL, Deisseignet PH, Roger P, Taourel P, Vernet H, Laffargue F. Pre-operative arterial embolisation of a uterine rhabdomyosarcoma in a 14-year-old girl. Br J Radiol. 2004;77(920):701–3.
Sam J, Price S. Embolization of a perineal rhabdomyosarcoma in a patient with priapism and disseminated intravascular coagulation. Hospital of the University of Pennsylvania. 2014 January 11; Available from: http://members.sirweb.org/members/caseclub/0798/0798_10/0798_10.htm.
Nagulic M, Prstojevic B, Simic R, Majstorovic B, Nikolic I. Resection of orbital rhabdomyosarcoma in an infant with the aid of preoperative partial arterial embolization. A case report. Neuroradiol J. 2007;20(6):699–703.
Bury M, Girault A, Megalizzi V, Spiegl-Kreinecker S, Mathieu V, Berger W, et al. Ophiobolin A induces paraptosis-like cell death in human glioblastoma cells by decreasing BKCa channel activity. Cell Death Dis. 2013;4:1–11.
Simpson R, Mathivanan S. Extracellular microvesicles: the need for internationally recognised nomenclature and stringent purification criteria. J Proteome Bioinforma. 2012;5:ii.
Hom C, Lu J, Liong M, Luo H, Li Z, Zink JI, et al. Mesoporous silica nanoparticles facilitate delivery of siRNA to shutdown signaling pathways in mammalian cells. Small. 2010;6(11):1185–90.
Ihara H, Kubota S, Uchimura A, Sakai Y, Wakiya T, Rahman MM, et al. A facile preparation method for self-assembled monolayers with silica particles on polystyrene-based microspheres. Mater Chem Phys. 2009;114(1):1–5.
Uchimura A, Kubota S, Yamada S, Wakiya T, Takafuji M, Shirosaki T, et al. Facile and versatile method for preparing core—shell microspheres with controlled surface structures based on silica particles-monolayer. Mater Chem Phys. 2011;129(3):871–80.
Evidente A, Andolfi A, Cimmino A, Vurro M, Fracchiolla M, Charudattan R. Herbicidal potential of ophiobolins produced by drechslera gigantea. J Agric Food Chem. 2006;54(5):1779–83.
Kafri T, van Praag H, Gage FH, Verma IM. Lentiviral vectors: regulated gene expression. Mol Ther. 2000;1(6):516–21.
Fox JEB, Phillips DR. Inhibition of actin polymerization in blood platelets by cytochalasins. Nature. 1981;292(5824):650–2.
Casella JF, Flanagan MD, Lin S. Cytochalasin D inhibits actin polymerization and induces depolymerization of actin filaments formed during platelet shape change. Nature. 1981;293(5830):302–5.
Krakstad C, Chekenya M. Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics. Mol Cancer. 2010;9(1):135.
Zhu G, Zheng Y, Zhang L, Shi Y, Li W, Liu Z, et al. Coxsackievirus A16 infection triggers apoptosis in RD cells by inducing ER stress. Biochem Biophys Res Commun. 2013;441(4):856–61.
Shi W, Li X, Hou X, Peng H, Jiang Q, Shi M, et al. Differential apoptosis gene expressions of rhabdomyosarcoma cells in response to enterovirus 71 infection. BMC Infect Dis. 2012;12(1):327.
Wang Y, Zhu X, Yang Z, Zhao X. Honokiol induces caspase-independent paraptosis via reactive oxygen species production that is accompanied by apoptosis in leukemia cells. Biochem Biophys Res Commun. 2013;430(3):876–82.
Shedden K, Xie XT, Chandaroy P, Chang YT, Rosania GR. Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. Cancer Res. 2003;63(15):4331–7.
Gregoraszczuk EL, Stoklosowa S. The effect of microtubule and microfilament-disrupting drugs on prolactin-stimulated progesterone synthesis and secretion by cultured porcine theca cells. Acta Histochem. 1997;99(2):207–15.
Schliwa M. Action of cytochalasin D on cytoskeletal networks. J Cell Biol. 1982;92(1):79–91.
Coleman ML, Sahai EA, Yeo M, Bosch M, Dewar A, Olson MF. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat Cell Biol. 2001;3(4):339–45.
Yano Y, Kambayashi JI, Shiba E, Sakon M, Oiki E, Fukuda K, et al. The role of protein phosphorylation and cytoskeletal reorganization in microparticle formation from the platelet plasma membrane. Biochem J. 1994;299:303–8.
Timár CI, Lőrincz ÁM, Csépányi-Kömi R, Vályi-Nagy A, Nagy G, Buzás EI, et al. Antibacterial effect of microvesicles released from human neutrophilic granulocytes. Blood. 2013;121(3):510–8.
Balaj L, Lessard R, Dai L, Cho Y-J, Pomeroy SL, Breakefield XO, et al. Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat Commun. 2011;2:180.
Guescini M, Genedani S, Stocchi V, Agnati L. Astrocytes and Glioblastoma cells release exosomes carrying mtDNA. J Neural Transm. 2010;117(1):1–4.
Bergsmedh A, Szeles A, Henriksson M, Bratt A, Folkman MJ, Spetz A-L, et al. Horizontal transfer of oncogenes by uptake of apoptotic bodies. Proc Natl Acad Sci. 2001;98(11):6407–11.
Waldenström A, Gennebäck N, Hellman U, Ronquist G. Cardiomyocyte microvesicles contain DNA/RNA and convey biological messages to target cells. PLoS ONE. 2012;7(4):e34653.
Huang X, Young NP, Townley HE. Characterisation and comparison of mesoporous silica particles for optimised drug delivery. Nanomater Nanotechnol. 2014;4:2.
Frickm CD, Rudin A, Wiley RH. Reactivity ratios for divinylbenzene and ethylene glycol dimethacrylate copolymerizations with styrene and methyl methacrylate. J Macromol Sci A Chem. 1981;16(7):1275–82.
Hata H, Saeki S, Kimura T, Sugahara Y, Kuroda K. Adsorption of taxol into ordered mesoporous silicas with various pore diameters. Chem Mater. 1999;11(4):1110–9.
Zhang R, Cherdhirankorn T, Graf K, Koynov K, Berger R. Swelling of cross-linked polystyrene beads in toluene. Microelectron Eng. 2008;85(5–6):1261–4.
He Q, Shi J. Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility. J Mater Chem. 2011;21(16):5845–55.
Karve S, Werner ME, Sukumar R, Cummings ND, Copp JA, Wang EC, et al. Revival of the abandoned therapeutic wortmannin by nanoparticle drug delivery. Proc Natl Acad Sci. 2012;109(21):8230–5.
ACKNOWLEDGMENTS AND DISCLOSURES
Xinyue Huang is thanked for the RD cells expressing GFP and Begbroke Nano is thanked for access to materials characterisation equipment. Neil Young is thanked for training and advice with regards to TEM. Dr. Maurizio Vurro and Maria Chira Zonno (Istituto di Scienze delle Produzioni Alimentari, CNR, Italy) are thanked for supplying culture filtrates of Drechslera gigantea as well as Dr. Fabiana Avolio (Dipartimento di Scienze Chimiche, Università di Napoli Federico II, Napoli, Italy) for her collaboration in Ophiobolin A purification. R. Morrison is funded by RCUK Digital Economy Programme grant number EP/G036861/1 (Oxford Centre for Doctoral Training in Healthcare Innovation). R. Kiss is a director of research with the Fonds National de la Recherche Scientifique (FNRS-FRS; Belgium). H. Townley would like to thank the Williams Fund for continuing support.
Author information
Authors and Affiliations
Corresponding author
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Figure S1
(DOCX 191 kb)
Rights and permissions
About this article
Cite this article
Morrison, R., Gardiner, C., Evidente, A. et al. Incorporation of Ophiobolin A into Novel Chemoembolization Particles for Cancer Cell Treatment. Pharm Res 31, 2904–2917 (2014). https://doi.org/10.1007/s11095-014-1386-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-014-1386-3